🇺🇸 FDA
Pipeline program

Intensive BP treatment group

2018YFC1312400

Unknown small_molecule completed

Quick answer

Intensive BP treatment group for Hypertension is a Unknown program (small_molecule) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
China SXT Pharmaceuticals
Indication
Hypertension
Phase
Unknown
Modality
small_molecule
Status
completed

Clinical trials